AI assistant
Sending…
CAPRICOR THERAPEUTICS, INC. — Director's Dealing 2015
Jan 23, 2015
33192_dirs_2015-01-22_92d7ad53-70ce-42b6-b2b3-f9a1ff004de9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK: 0001133869
Period of Report: 2015-01-21
Reporting Person: CEDARS SINAI MEDICAL CENTER (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-21 | Common Stock | P | 851546 | $3.5230 | Acquired | 2175632 | Direct |
Footnotes
F1: The Reporting Person entered into a Share Purchase Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on January 21, 2015, purchased an aggregate of 851,546 shares of the Issuer's common stock at a purchase price of $3.5230 per share for total cash proceeds of approximately US$3,000,000.
More from CAPRICOR THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 28
Share Issue/Capital Change
2026
Jan 30
Major Shareholding Notification
2026
Jan 26
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7